Plasma Homocysteine Levels Increased Risk of Levodopa-Induced Dyskinesia in Parkinson's Disease

被引：0
|
作者：
Lin, J. J.
Yueh, K. Y.
机构：
来源：
MOVEMENT DISORDERS | 2010年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S674 / S674
页数：1
相关论文
共 50 条
  • [41] Diagnostic prediction model for levodopa-induced dyskinesia in Parkinson's disease
    Santos-Lobato, Bruno Lopes
    Schumacher-Schuh, Artur F.
    Rieder, Carlos R. M.
    Hutz, Mara H.
    Borges, Vanderci
    Ferraz, Henrique Ballalai
    Mata, Ignacio F.
    Zabetian, Cyrus P.
    Tumas, Vitor
    ARQUIVOS DE NEURO-PSIQUIATRIA, 2020, 78 (04) : 206 - 216
  • [42] Levodopa-induced dyskinesia in Parkinson's disease: Epidemiology, etiology, and treatment
    Zesiewicz, Theresa A.
    Sullivan, Kelly L.
    Hauser, Robert A.
    CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS, 2007, 7 (04) : 302 - 310
  • [43] Chemical management of levodopa-induced dyskinesia in Parkinson's disease patients
    Dragasevic-Miskovic, Natasa
    Petrovic, Igor
    Stankovic, Iva
    Kostic, Vladimir S.
    EXPERT OPINION ON PHARMACOTHERAPY, 2019, 20 (02) : 219 - 230
  • [44] A Web Resource for Levodopa-Induced Dyskinesia Genetics in Parkinson’s Disease
    Hagen Blankenburg
    Marika Falla
    Christine Schwienbacher
    Giovanni Fabbrini
    Alfredo Berardelli
    Peter P. Pramstaller
    Francisco S. Domingues
    Neuroinformatics, 2017, 15 : 297 - 300
  • [45] High levodopa plasma concentration after oral administration predicts levodopa-induced dyskinesia in Parkinson's disease
    Shiraishi, Tomotaka
    Nishikawa, Noriko
    Mukai, Yohei
    Takahashi, Yuji
    PARKINSONISM & RELATED DISORDERS, 2020, 75 : 80 - 84
  • [46] Metabolic Profile in Plasma AND CSF of LEVODOPA-induced Dyskinesia in Parkinson's Disease: Focus on Neuroinflammation
    Santos-Lobato, Bruno L.
    Gardinassi, Luiz Gustavo
    Bortolanza, Mariza
    Peti, Ana Paula Ferranti
    Pimentel, Angela V.
    Faccioli, Lucia Helena
    Del-Bel, Elaine A.
    Tumas, Vitor
    MOLECULAR NEUROBIOLOGY, 2022, 59 (02) : 1140 - 1150
  • [47] Metabolic Profile in Plasma AND CSF of LEVODOPA-induced Dyskinesia in Parkinson’s Disease: Focus on Neuroinflammation
    Bruno L. Santos-Lobato
    Luiz Gustavo Gardinassi
    Mariza Bortolanza
    Ana Paula Ferranti Peti
    Ângela V. Pimentel
    Lúcia Helena Faccioli
    Elaine A. Del-Bel
    Vitor Tumas
    Molecular Neurobiology, 2022, 59 : 1140 - 1150
  • [48] Risk factors of levodopa-induced dyskinesia in Parkinson's disease: results from the PPMI cohort
    Eusebi, Paolo
    Romoli, Michele
    Paoletti, Federico Paolini
    Tambasco, Nicola
    Calabresi, Paolo
    Parnetti, Lucilla
    NPJ PARKINSONS DISEASE, 2018, 4
  • [49] Risk factors and predictors of levodopa-induced dyskinesia among multiethnic Malaysians with Parkinson's disease
    Hashim, H. Z.
    Norlinah, M. I.
    Nafisah, W. Y.
    Tan, H. J.
    Raymond, A. A.
    Tamil, A. M.
    INTERNATIONAL JOURNAL OF NEUROSCIENCE, 2014, 124 (03) : 187 - 191
  • [50] Risk factors of levodopa-induced dyskinesia in Parkinson’s disease: results from the PPMI cohort
    Paolo Eusebi
    Michele Romoli
    Federico Paolini Paoletti
    Nicola Tambasco
    Paolo Calabresi
    Lucilla Parnetti
    npj Parkinson's Disease, 4
12345